Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria

医学 宫颈癌 核医学 颈淋巴结 淋巴 放射科 医学物理学 癌症 内科学 病理 转移
作者
J. E. Snyder,A. Willett,Wenqing Sun,Yusung Kim
出处
期刊:Practical radiation oncology [Elsevier]
卷期号:9 (2): e156-e163 被引量:5
标识
DOI:10.1016/j.prro.2018.10.012
摘要

This study aimed to examine the feasibility of stereotactic body radiation therapy (SBRT) as an external beam radiation therapy boost to positron emission tomography (PET) positive lymph nodes (LN) in patients with cervical cancer and to evaluate overall tumor control probability (TCP) increase.Ten patients with cervical cancer and PET positive LN metastasis who received external beam radiation therapy (45 Gy), followed by a 3-dimensional conformal radiation therapy boost (5.4-9 Gy) and tandem-and-ovoid high-dose-rate brachytherapy (16-30 Gy) were retrospectively enrolled in this study. SBRT plans were generated using 21 Gy, 24 Gy, or 30 Gy as a replacement for 3-dimensional conformal radiation therapy boost. The 2 Gy-per-fraction equivalent dose maps were made using an α/β value of 10 for PET positive LNs and 3 for organs at risk (OARs). TCP values were calculated using a logistic TCP model, where 2 input parameters (D50 and Gamma50 = 2) were modeled by 2 clinical outcomes: our institution and the literature. OAR sparing was evaluated using Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC) dose limits.Thirty percent of 10 patients receiving conventional boost experienced recurrence. The TCP of the SBRT schemes was 88% ± 7% (97% ± 2%; 21 Gy), 96% ± 1% (99% ± 0%; 24 Gy), and 99% ± 1% (100% ± 0%; 30 Gy), and the conventional LN-boost TCP value was 25% ± 11% (58% ± 15%) when TCP input parameters were based on published clinical outcome data for LN SBRT treatments (institutional outcome data). The tumor coverage doses (D90) of the SBRT boost plans were on average 32.34 Gyαβ=10 (21 Gy), 37.78 Gyαβ=10 (24 Gy), and 55.54Gyαβ=10 (30 Gy) higher than the conventional LN boost plan. The QUANTEC OAR dose constraints were met for the bladder, rectum, and bowel in all cases for the SBRT LN 21 Gy group, and in 90% and 70% of cases in the SBRT LN 24 Gy and SBRT LN 30 Gy groups, respectively.An SBRT boost dose of 30 Gy can be delivered without compromising QUANTEC OAR limits. The use of SBRT increases TCP values, regardless of the input parameters.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yu完成签到 ,获得积分10
刚刚
hxy发布了新的文献求助10
刚刚
烟花应助conlensce采纳,获得10
2秒前
3秒前
3秒前
4秒前
4秒前
xixi发布了新的文献求助10
4秒前
yyy完成签到,获得积分20
5秒前
隐形曼青应助小高同学采纳,获得10
5秒前
6秒前
swy发布了新的文献求助10
7秒前
ddd发布了新的文献求助10
8秒前
共享精神应助无限水杯采纳,获得30
8秒前
ni发布了新的文献求助10
9秒前
纸飞机完成签到,获得积分10
11秒前
夏生发布了新的文献求助10
11秒前
12秒前
12秒前
xixi完成签到,获得积分10
12秒前
13秒前
成长完成签到,获得积分10
13秒前
13秒前
wang完成签到,获得积分10
14秒前
科目三应助swy采纳,获得10
14秒前
核动力驴完成签到,获得积分10
14秒前
杨哥四世发布了新的文献求助10
15秒前
15秒前
16秒前
wang发布了新的文献求助10
17秒前
英俊的铭应助夏生采纳,获得10
17秒前
18秒前
暴躁的马里奥完成签到,获得积分10
18秒前
20秒前
ni完成签到,获得积分10
22秒前
22秒前
23秒前
23秒前
cissie完成签到 ,获得积分10
23秒前
王万万完成签到,获得积分10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 3000
Les Mantodea de guyane 2500
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 2000
Signals, Systems, and Signal Processing 510
Discrete-Time Signals and Systems 510
Brittle Fracture in Welded Ships 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5945168
求助须知:如何正确求助?哪些是违规求助? 7097505
关于积分的说明 15898544
捐赠科研通 5077181
什么是DOI,文献DOI怎么找? 2730290
邀请新用户注册赠送积分活动 1690245
关于科研通互助平台的介绍 1614551